Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-25-117922
Filing Date
2025-05-12
Accepted
2025-05-12 17:25:01
Documents
21

Document Format Files

Seq Description Document Type Size
1 S-3 d946899ds3.htm S-3 415033
2 EX-4.5 d946899dex45.htm EX-4.5 270084
3 EX-4.6 d946899dex46.htm EX-4.6 272654
4 EX-5.1 d946899dex51.htm EX-5.1 15737
5 EX-5.2 d946899dex52.htm EX-5.2 9085
6 EX-23.1 d946899dex231.htm EX-23.1 1639
7 EX-FILING FEES d946899dexfilingfees.htm   iXBRL EX-FILING FEES 99416
8 GRAPHIC g946899g0512011331337.jpg GRAPHIC 2584
9 GRAPHIC g946899g09n64.jpg GRAPHIC 52988
  Complete submission text file 0001193125-25-117922.txt   1395735

Data Files

Seq Description Document Type Size
23 EXTRACTED XBRL INSTANCE DOCUMENT d946899dexfilingfees_htm.xml XML 37839
Mailing Address 201 BROOKLINE AVENUE SUITE 901 BOSTON MA 02215
Business Address 201 BROOKLINE AVENUE SUITE 901 BOSTON MA 02215 (857) 320-4900
Tango Therapeutics, Inc. (Filer) CIK: 0001819133 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-287202 | Film No.: 25936152
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)